证券代码：002440 证券简称：闰土股份 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2019-001 | --- | --- | --- | |-------------------|----------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | | □ 现场参观 | | | | √ 其他 一对一及一对多交流 | | | 参与单位名称及 | 摩根士丹利（吕洪良） 1、中国银河国际（刘颖）， | 2 、天达资产 ...

证券代码：002440 证券简称：闰土股份 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2019-002 | --- | --- | --- | --- | |----------------|---------------------------|----------------------------------------|--------------------------------------------------------------| | | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | | 类别 | □ | 媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | | □ 现场参观 | | | | | □ 其他 | | | | 参与单位名称及 | | | 长江证券（施航），中信产业基金（李国洪），东方证券 | | 人员姓名 | | | （郭哲）、东北证券（陈俊杰、樊翔宇），敦和资管（梁作 | | | | 基金（蒋文超）、华泰保兴基金（黄佳丽） | 强），中泰证券资管（程枫），常青藤资管（冯先涛）、华夏 | | | | ...

1 证券代码：002440 证券简称：闰土股份 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2022-002 | --- | --- | --- | |-----------------------|-----------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | √特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □其他 | | | 参与单位名称及 | 海通证券 李博 | | | 人员姓名 | 宁泉资产 邱炜佳 | | | 时间 2022 | 年 11 月 23 日 | 下午 15:00-17 ...

证券代码：002440 证券简称：闰土股份 1 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2021-001 | --- | --- | --- | |-------------------|-----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | □特定对象调研 | □分析师会议 | | 类别 | □媒体采访 √业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □现场参观 ...

1 证券代码：002440 证券简称：闰土股份 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2022-001 | --- | --- | --- | |-------------------|------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | □特定对象调研 □分析师会议 | | | | □媒体采访 √业绩说明会 | | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □其他 | | | 参与单位名称及 | 通过全景网网络平台参与公司 ...

浙江闰土股份有限公司 2022 年第三季度报告 证券代码：002440 证券简称：闰土股份 公告编号：2022-028 浙江闰土股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 浙江闰土股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |-----------------------------------------------------|-------------------|-------------------------|--------------- ...

Financial Performance - The company reported a revenue of 1.2 billion RMB for the first half of 2022, representing a year-on-year increase of 15%[23]. - The net profit attributable to shareholders for the same period was 200 million RMB, up 10% compared to the previous year[23]. - The company's operating revenue for the reporting period reached ¥3,419,968,468.85, representing a year-on-year increase of 24.12%[30]. - The net profit attributable to shareholders was ¥499,651,175.24, up 24.69% compared to the same period last year[30]. - The net cash flow from operating activities increased significantly by 113.94%, amounting to ¥1,218,596,558.73[30]. - The total assets at the end of the reporting period were ¥12,722,178,984.54, reflecting an 11.29% increase from the previous year[30]. - The operating cost increased by 30.59% to ¥2,570,459,814.26 from ¥1,968,303,412.78, primarily due to the growth in operating revenue[47]. - The company achieved a gross profit of ¥66,983,320, representing a year-on-year growth of 29.44%[39]. - The company reported a significant increase in other income, which rose by 77.54% to ¥146,734,066.14, mainly due to increased government subsidies[49]. - The company reported a net profit for the first half of 2022 of ¥495,630,793.37, representing a 27.2% increase from ¥389,574,663.31 in the previous year[200]. Investment and Growth Strategies - The company plans to increase its investment in environmental protection by 20% in response to the new environmental laws[11]. - The company aims to expand its market share by 5% in the next year through strategic adjustments in procurement and sales[12]. - The company is focusing on the development of new dye products, with an expected launch of three new products by the end of 2022[23]. - The company has been focusing on "backward integration" strategies, enhancing its supply chain and production processes[39]. - The company reported a significant increase in R&D investment to improve production processes and promote new product development[39]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[200]. Environmental Compliance and Initiatives - The company has achieved compliance with emission standards for various pollutants, including SO2 and NOX, across its production facilities[104]. - The company’s COD emissions from Dibang Chemical were 56.301 tons, with a permitted limit of 149.22 tons per year, indicating compliance with standards[94]. - The company has established five sets of 200t/h MVR devices and two sets of 60t/h multi-effect concentration devices for resource recovery of low-concentration acidic wastewater and saline wastewater, with a daily treatment capacity of 20,000 tons[103]. - The company has implemented a comprehensive hazardous waste management system, ensuring proper storage and disposal in compliance with relevant regulations[105]. - The company has established a wastewater treatment station with a daily capacity of 20,000 tons, which processes both production and domestic wastewater[103]. - The company has implemented an environmental emergency response plan and has filed it with local environmental protection authorities[109]. Financial Management and Investments - The company has ongoing equity investments totaling ¥290,000,000.00, with significant stakes in various companies, including a 20% stake in Jiangxi Huaju Energy Technology Co., Ltd.[67]. - The total approved guarantee amount for subsidiaries is CNY 77,000 million, with actual guarantees incurred during the reporting period amounting to CNY 13,300 million[144]. - The total amount of entrusted financial management is CNY 79,950 million, with no overdue amounts or impairment provisions recorded[147]. - The company has invested CNY 62,000 million in bank financial products, CNY 3,000 million in broker financial products, and CNY 14,950 million in trust financial products[147]. - The company maintains a diversified investment strategy through various financial products, enhancing its financial stability and growth potential[147]. Shareholder Information and Corporate Governance - The company reported a participation rate of 46.35% in the 2021 annual shareholders' meeting held on May 20, 2022[87]. - The company does not plan to distribute cash dividends or issue bonus shares for the half-year period[89]. - The total number of common shareholders at the end of the reporting period was 40,941[167]. - The largest shareholder, Zhang Aijuan, holds 16.73% of shares, totaling 192,454,893 shares[169]. - The company repurchased a total of 26,500,095 shares, accounting for 2.3034% of the total share capital[169]. - The company’s financial report for the half-year period was not audited[183]. Risk Management - The company has identified risks related to raw material price fluctuations, which could impact production costs and overall performance[12]. - The company is closely monitoring macroeconomic trends to adjust its business strategies accordingly[8]. - The company faces market risks due to macroeconomic conditions and commodity price volatility, which can impact production costs and performance[84]. - The company has a dedicated team responsible for risk assessment and management of derivatives trading, including representatives from finance, auditing, and legal departments[71].

Financial Performance - The company aims to achieve a total operating revenue of no less than 6 billion RMB and a total profit of no less than 1 billion RMB in 2022[5]. - The profit distribution plan proposes a cash dividend of 3.5 RMB (including tax) for every 10 shares, totaling approximately 393.4 million RMB[11]. - The company's operating revenue for 2021 was ¥5,572,265,054.85, representing a 6.58% increase compared to ¥5,228,130,173.91 in 2020[36]. - The net profit attributable to shareholders for 2021 was ¥835,615,920.37, a 6.02% increase from ¥788,176,752.31 in 2020[36]. - The net profit after deducting non-recurring gains and losses was ¥607,377,790.11, up 9.19% from ¥556,262,543.48 in 2020[36]. - The company achieved a total revenue of 5.57 billion yuan in 2021, representing a year-on-year growth of 6.58%[82]. - The company's net profit attributable to shareholders was 836 million yuan, an increase of 6.02% compared to the previous year[79]. - The total revenue for the company reached 255.66 million, with a significant increase of 5.5% compared to the previous period[166]. - The company reported a net profit of 250.16 million, reflecting a growth of 4.5% year-over-year[166]. Research and Development - The company will continue to invest in research and development of new products and technologies to support market expansion and competitiveness[5]. - The company invested approximately 249.81 million yuan in R&D during the reporting period, resulting in 25 authorized invention patents and 5 utility model patents[77]. - The company has applied for 222 invention patents and 18 utility model patents related to its core technologies in dye production, indicating a strong R&D capability[66]. - The company is focusing on technological innovation and has been recognized as a key enterprise research institute by the Zhejiang Provincial Science and Technology Department[81]. - The company plans to enhance R&D investment and improve production processes to strengthen its competitive edge in the dye industry[138]. - The company has allocated 1.5 million for research and development to enhance product offerings and technology[167]. Market and Industry Dynamics - The company will closely monitor national macroeconomic trends and adjust its development strategies accordingly to mitigate risks from policy changes in the textile dyeing industry[6]. - The company plans to implement flexible strategies to manage market risks, including price fluctuations and increased competition in the dyeing industry[10]. - The company maintains a leading market share in the domestic dye market, ranking among the top two in terms of sales[58]. - The dye industry is highly competitive, with increased domestic supply leading to intensified market competition, potentially resulting in lower sales prices or reduced capacity utilization[148]. - The company is responding to stricter environmental regulations by upgrading production equipment and increasing investment in environmental technology[54]. Environmental and Safety Initiatives - The company emphasizes safety production and will increase investments in safety management, adopting advanced safety management methods[7]. - Environmental protection investments will continue to increase, impacting upstream raw material suppliers and the company's operational strategies[10]. - The company is committed to resource recycling and emission reduction, which has improved operational efficiency and reduced environmental pressure[57]. - The company aims to achieve a green and low-carbon transformation in line with national policies during the "14th Five-Year Plan" period[50]. - The company is committed to increasing environmental protection investments to comply with new regulations and ensure sustainable operations[147]. Operational Efficiency - The company will enhance its procurement strategies to ensure a stable supply of raw materials in response to market trends[10]. - The company has implemented a "backward integration" strategy to extend its industrial chain, reduce production costs, and mitigate the impact of intermediate price fluctuations on operations[57]. - The company has established a complete industrial chain from thermal power, steam, chlorine, and caustic soda to intermediates and dyes, enhancing its market risk resilience[76]. - The company employs a production management model that combines make-to-order for non-standard products and stockpiling for conventional products[62]. - The company has a self-built 30MW cogeneration project to reduce overall electricity costs, with electricity costs accounting for 62% of caustic soda production costs[72]. Financial Management - The company has no fundraising activities during the reporting period, indicating a stable financial position[131]. - The company has not engaged in any major asset or equity sales during the reporting period, maintaining its asset base[132][134]. - The company reported a significant decrease in net cash increase of -¥951,796,624.99, compared to an increase of ¥1,047,082,104.84 in the previous year, reflecting a 190.90% decline[105]. - The company has established risk management measures for derivative trading, including market risk and credit risk assessments[127]. Human Resources - The total number of employees at the end of the reporting period was 5,141, with 491 in the parent company and 4,650 in major subsidiaries[196]. - The professional composition of employees includes 3,659 production personnel, 93 sales personnel, 722 technical personnel, 76 financial personnel, and 591 administrative personnel[196]. - The company has established a competitive compensation and benefits system, including medical assistance funds and special subsidies, to create a favorable working environment for employees[200]. Corporate Governance - The total remuneration for directors, supervisors, and senior management in 2020 was 8.4133 million CNY, while for 2021, it was confirmed to be 7.42 million CNY[181]. - The independent director allowance was set at 120,000 CNY per person per year, as approved by the board[181]. - The company held four board meetings in 2021, with significant resolutions including the approval of the 2021 Q1 report and the 2021 semi-annual report[185]. - The total remuneration for the board members in 2021 was 821.50 thousand CNY, with individual payments varying among members[183].

浙江闰土股份有限公司 2022 年第一季度报告全文 1 证券代码：002440 证券简称：闰土股份 公告编号：2022-017 浙江闰土股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |----------------------------------------------------|-------------------|-------------------|---------------------------| | | 本报告期 | 上年同期 | ...

[Key Financial Data](index=1&type=section&id=I.%20Key%20Financial%20Data) The company achieved double-digit revenue and net profit growth in Q1-Q3 2021, with Q3 net profit significantly boosted by non-recurring gains, while operating cash flow declined due to reduced subsidies and increased procurement [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1-Q3 2021, the company's operating revenue reached CNY 4.25 billion with 16.33% growth, and net profit attributable to shareholders was CNY 669 million with 20.10% growth Key Financial Indicators for Q1-Q3 and Q3 2021 | Indicator | Year-to-Date (YTD) | YTD YoY Change | Current Period (Q3) | Current Period YoY Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (CNY) | 4,251,112,041.11 | 16.33% | 1,495,737,939.70 | 7.69% | | Net Profit Attributable to Parent Company Shareholders (CNY) | 668,701,306.65 | 20.10% | 267,998,253.29 | 47.71% | | Net Profit Attributable to Parent Company Shareholders Excluding Non-recurring Gains and Losses (CNY) | 466,372,546.81 | 26.41% | 159,296,198.83 | -11.03% | | Net Cash Flow from Operating Activities (CNY) | 777,555,218.29 | -49.25% | - | - | | Basic Earnings Per Share (CNY/share) | 0.59 | 22.92% | 0.240 | 50.00% | [Non-recurring Gains and Losses Items and Amounts](index=1&type=section&id=Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) In Q1-Q3 2021, non-recurring gains and losses totaled approximately CNY 202 million, significantly impacting net profit, primarily from fair value changes in the investment in Guobang Pharmaceutical and government subsidies 2021 Q1-Q3 Major Non-recurring Gains and Losses Items | Item | Year-to-Date Amount (CNY) | Explanation | | :--- | :--- | :--- | | Gains and Losses from Changes in Fair Value of Trading Financial Assets and Liabilities | 154,943,917.13 | Primarily due to fair value changes in the investment in Guobang Pharmaceutical in the current period | | Government Subsidies Included in Current Period Profit/Loss | 86,455,670.98 | - | | **Total** | **202,328,759.84** | **--** | [Analysis of Key Financial Indicator Changes](index=2&type=section&id=Analysis%20of%20Key%20Financial%20Indicator%20Changes) Several financial indicators showed significant year-on-year changes, including substantial increases in prepayments and other non-current assets, a shift from short-term to long-term debt, and a decrease in operating cash flow due to reduced government subsidies and increased procurement - Balance sheet items showed significant changes, primarily in: - **Prepayments**: Increased by **103.99%** year-on-year due to increased prepayments for raw materials[7](index=7&type=chunk) - **Other Non-current Assets**: Increased by **261.51%** year-on-year due to increased prepayments for equipment[7](index=7&type=chunk) - **Short-term Borrowings**: Decreased by **90.82%** year-on-year due to repayment of borrowings[7](index=7&type=chunk) - **Long-term Borrowings**: Increased by **150.00%** year-on-year due to increased long-term bank borrowings[7](index=7&type=chunk) - **Treasury Stock**: Increased by **433.24%** year-on-year due to company share repurchases[7](index=7&type=chunk) - Income statement item changes were mainly due to: - **Selling Expenses**: Decreased by **51.70%** year-on-year because transportation costs were reclassified to operating costs under new revenue standards[10](index=10&type=chunk) - **R&D Expenses**: Increased by **51.14%** year-on-year as current period investment returned to normal levels after a lower base in the prior year due to the pandemic[10](index=10&type=chunk) - **Other Income** and **Non-operating Income**: Decreased by **54.34%** and **85.31%** year-on-year respectively, primarily due to reduced government subsidies received[10](index=10&type=chunk) - Net cash flow from operating activities decreased by **49.25%** year-on-year, mainly due to reduced government subsidies received, increased cash payments for raw material purchases (**+65.95%**), and increased tax payments (**+128.21%**)[10](index=10&type=chunk) [Shareholder Information](index=3&type=section&id=II.%20Shareholder%20Information) As of the reporting period end, the company had 38,244 shareholders, with a concentrated ownership structure where the controlling shareholder's family members collectively hold over 38% of shares, and the company completed a share repurchase plan representing 2.3034% of total share capital Top Three Shareholders' Holdings | Shareholder Name | Shareholder Nature | Shareholding Percentage | | :--- | :--- | :--- | | Zhang Aijuan | Domestic Natural Person | 16.73% | | Ruan Jingbo | Domestic Natural Person | 15.76% | | Ruan Jingxi | Overseas Legal Person | 5.58% | - Controlling shareholders Ruan Jingbo, Zhang Aijuan (Ruan Jingbo's mother), and Ruan Jingxi (Ruan Jingbo's sister) are parties acting in concert, indicating a concentrated equity structure[14](index=14&type=chunk) - As of July 16, 2021, the company completed its share repurchase plan, repurchasing a total of **26,500,095 shares** through centralized bidding, accounting for **2.3034%** of the company's total share capital[14](index=14&type=chunk) [Other Significant Matters](index=4&type=section&id=III.%20Other%20Significant%20Matters) During the reporting period, the company completed its share repurchase plan, expending approximately CNY 255 million, and its investment in Guobang Pharmaceutical Group Co., Ltd. through an M&A fund yielded significant book value growth and fair value change gains following its successful listing - The company's share repurchase plan was completed, with a cumulative repurchase of **26,500,095 shares**, representing **2.3034%** of total share capital, at a total cost of **CNY 255 million** (excluding transaction fees)[17](index=17&type=chunk) - Guobang Pharmaceutical, in which the company holds a stake through an M&A fund, was listed on the Shanghai Stock Exchange on August 2, 2021; as of the reporting period end, the company held **6.25 million shares**, representing **1.12%** of its total share capital, with a book value of **CNY 174 million**[17](index=17&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=IV.%20Quarterly%20Financial%20Statements) As of September 30, 2021, the company's total assets were CNY 11.601 billion, with a healthy asset-liability ratio of 18.73%; Q1-Q3 2021 operating revenue was CNY 4.251 billion, net profit attributable to parent company shareholders was CNY 669 million, and net cash flow from operating activities was CNY 778 million, maintaining positive inflow despite a year-on-year decrease [Consolidated Balance Sheet](index=5&type=section&id=Consolidated%20Balance%20Sheet) As of September 30, 2021, the company's total assets were CNY 11.601 billion, a 2.17% increase from the beginning of the year, with total liabilities of CNY 2.173 billion resulting in a low asset-liability ratio of 18.73%, and total equity attributable to parent company shareholders was CNY 9.259 billion, up 1.16% from year-start Balance Sheet Major Items (Unit: CNY) | Item | September 30, 2021 | December 31, 2020 | | :--- | :--- | :--- | | Total Assets | 11,600,884,782.17 | 11,354,172,670.91 | | Total Liabilities | 2,173,303,786.19 | 2,014,129,580.06 | | Total Equity Attributable to Parent Company Shareholders | 9,258,740,754.19 | 9,152,853,542.48 | [Consolidated Income Statement](index=7&type=section&id=Consolidated%20Income%20Statement) In Q1-Q3 2021, the company's total operating revenue reached CNY 4.251 billion, a 16.33% year-on-year increase, with total operating costs of CNY 3.696 billion, up 14.29% year-on-year, and net profit attributable to parent company shareholders was CNY 669 million, growing 20.10% year-on-year, significantly boosted by CNY 154 million in fair value change gains 2021 Q1-Q3 Income Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | I. Total Operating Revenue | 4,251,112,041.11 | 3,654,209,230.30 | | II. Total Operating Costs | 3,696,152,018.40 | 3,234,117,772.89 | | Gains from Changes in Fair Value | 153,548,296.75 | 204,084.95 | | IV. Total Profit | 857,208,393.75 | 684,623,577.31 | | Net Profit Attributable to Parent Company Shareholders | 668,701,306.65 | 556,787,261.14 | | Basic Earnings Per Share | 0.59 | 0.48 | [Consolidated Cash Flow Statement](index=9&type=section&id=Consolidated%20Cash%20Flow%20Statement) In Q1-Q3 2021, net cash flow from operating activities was CNY 778 million, a 49.25% year-on-year decrease primarily due to reduced government subsidies and increased procurement payments, while net cash outflow from investing activities was CNY 579 million and from financing activities was CNY 648 million, resulting in a period-end cash and cash equivalents balance of CNY 1.581 billion, a decrease of CNY 452 million from the beginning of the year 2021 Q1-Q3 Cash Flow Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 777,555,218.29 | 1,532,192,284.44 | | Net Cash Flow from Investing Activities | -579,446,251.83 | -6,592,719.72 | | Net Cash Flow from Financing Activities | -647,978,425.45 | -346,916,436.01 | | Net Increase in Cash and Cash Equivalents | -452,193,708.36 | 1,176,896,869.53 | | Cash and Cash Equivalents at Period End | 1,580,635,526.51 | 2,162,643,999.56 |